SAGE Therapeutics's total assets for Q2 2025 were $422.92M, a decrease of -9.95% from the previous quarter. SAGE total liabilities were $54.19M for the fiscal quarter, a -9.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.